New developments in transcatheter therapy of mitral valve disease.
Ontology highlight
ABSTRACT: Mitral valve regurgitation (MR) belongs to one of the most common acquired valve diseases in western countries with increasing prevalence in older age. For patients with high perioperative risk and older age prohibitive for valve surgery, the development of transcatheter mitral valve therapies offers new options. Assessment of the severity and etiology of MR and thorough imaging of the mitral valve anatomy and pathology are necessary prerequisites for appropriate decision making in the field of transcatheter mitral valve therapies. Different transcatheter repair and replacement techniques are on the market, most of them mimicking surgical techniques. With some techniques (e.g., the MitraClip device), there is good clinical experience (>80,000 devices implanted worldwide), and evidence (thr
SUBMITTER: Walther C
PROVIDER: S-EPMC7212154 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA